Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
Titel:
Efbemalenograstim alfa, an Fc fusion protein, long-acting granulocyte-colony stimulating factor for reducing the risk of febrile neutropenia following chemotherapy: results of a phase III trial
Auteur:
Glaspy, John Bondarenko, Igor Burdaeva, Olga Chen, Jianmin Rutty, Dean Li, Renshu Wang, Shufang Hou, Qingsong Li, Simon